Literature DB >> 6095851

Phencyclidine receptors in rat brain cortex.

L G Mendelsohn, G A Kerchner, V Kalra, D M Zimmerman, J D Leander.   

Abstract

The binding of [3H]phencyclidine (PCP) to receptors in rat brain cortex has been studied. Two receptors have been detected, a high affinity receptor site with a KD of 23.5 +/- 7.4 nM and a low affinity site with a KD of 7.6 +/- 1.8 microM. The binding of [3H]PCP to its receptors was pH and temperature dependent and was destroyed by heat-denaturation. The binding of [3H]PCP was inhibited by compounds which produce PCP-like behavioral effects including dexoxadrol, etoxadrol and ketamine as well as a novel series of benz(f)isoquinolines. The low affinity site was blocked by PCP, etoxadrol and (+)-SKF-10,047 but not morphine or leu-enkephalin, suggesting that it also represents a specific PCP site. Stereoselective displacement of PCP at the high affinity receptor was observed with the isomers of cyclazocine, cyclorphan, SKF-10,047 and dioxadrol (dexoxadrol and levoxadrol). Naloxone, 4,5,6,7-tetrahydroisoxazolo(S,4-C)pyridin-3-ol (THIP) hydrate and haloperidol inhibited binding poorly (Ki greater than 1 microM), suggesting that these compounds do not interact significantly with the high affinity PCP receptor in vivo. The affinity of ligands for the phencyclidine receptor was highly correlated (r = 0.714, P less than 0.01) with their potency to produce catalepsy in pigeons.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095851     DOI: 10.1016/0006-2952(84)90133-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  A rapid method for evaluating the behavioral effects of phencyclidine-like dissociative anesthetics in mice.

Authors:  G E Evoniuk; R P Hertzman; P Skolnick
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 2.  Neuropsychopharmacological understanding for therapeutic application of morphinans.

Authors:  Eun-Joo Shin; Jau-Shyong Hong; Hyoung-Chun Kim
Journal:  Arch Pharm Res       Date:  2010-10-30       Impact factor: 4.946

Review 3.  Ketamine and phencyclidine: the good, the bad and the unexpected.

Authors:  D Lodge; M S Mercier
Journal:  Br J Pharmacol       Date:  2015-07-28       Impact factor: 8.739

4.  Ketamine self-administration in the rat: evidence for a critical role of setting.

Authors:  Maria Teresa De Luca; Aldo Badiani
Journal:  Psychopharmacology (Berl)       Date:  2010-10-31       Impact factor: 4.530

5.  The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.

Authors:  L J Bristow; P H Hutson; L Thorn; M D Tricklebank
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

6.  An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat.

Authors:  K Ren; M J Iadarola; R Dubner
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

7.  Phencyclidine binds to blood platelets with high affinity and specifically inhibits their activation by adrenaline.

Authors:  G A Jamieson; A K Agrawal; N J Greco; T E Tenner; G D Jones; K C Rice; A E Jacobson; J G White; N N Tandon
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

8.  Quantitative autoradiography of brain binding sites for the vesicular acetylcholine transport blocker 2-(4-phenylpiperidino)cyclohexanol (AH5183).

Authors:  M R Marien; S M Parsons; C A Altar
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

9.  Antagonism of phencyclidine action by metaphit in rat cerebellar Purkinje neurons: an electrophysiological study.

Authors:  Y Wang; M Palmer; R Freedman; B Hoffer; M V Mattson; R A Lessor; K C Rice; A E Jacobson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

10.  An electrophilic affinity ligand based on (+)-MK801 distinguishes PCP site 1 from PCP site 2.

Authors:  H C Akunne; J A Monn; A Thurkauf; A E Jacobson; K C Rice; J T Linders; Q Jiang; F Porreca; R B Rothman
Journal:  Neurochem Res       Date:  1994-04       Impact factor: 3.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.